OPKO Health, Inc. Total Contract Liability
OPKO Health, Inc. (OPK) had Total Contract Liability of $7.00 thousand as of 2023-12-31, per its 10-K filed 2024-03-01.
Discontinued › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2024-03-01
- 2023-12-31: Contract with Customer, Liability $7.00K.
- 2023-09-30: Contract with Customer, Liability $136.00K.
- 2023-06-30: Contract with Customer, Liability $140.00K.
- 2023-03-31: Contract with Customer, Liability $140.00K.
| Period end | Contract with Customer, Liability | Contract with Customer, Liability as first filed |
|---|---|---|
| 2023-12-31 | $7.00K 10-K · filed 2024-03-01 | |
| 2023-09-30 | $136.00K 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $140.00K 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $140.00K 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $138.00K 10-K · filed 2024-03-01 | |
| 2022-09-30 | $393.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $449.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $462.00K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $466.00K 10-K · filed 2023-02-27 | |
| 2021-09-30 | $3.36M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $8.95M 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $15.59M 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $16.38M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $17.05M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $17.70M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $12.30M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $21.77M 10-K · filed 2021-02-18 | $21.80M 10-K · filed 2020-03-02 |
| 2019-09-30 | $34.20M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $54.10M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $73.00M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $91.10M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $89.80M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $109.60M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $125.00M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $152.30M 10-K · filed 2019-03-01 | $140.40M 10-Q · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |